Log In
BCIQ
Print this Print this
 

OraVerse, phentolamine (formerly NV-101)

  Manage Alerts
Collapse Summary General Information
Company Septodont Holdings S.A.S.
DescriptionInjectable formulation of the vasodilator phentolamine mesylate
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAnesthesia
Indication DetailsReversal of soft tissue anesthesia following routine dental procedures; Reverse dental anesthesia
Regulatory Designation
PartnerSanofi

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today